Gene · 11065
Papers2,651
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,651
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Time-resolved cryo-EM (TR-EM) analysis of substrate polyubiquitination by the RING E3 anaphase-promoting complex/cyclosome (APC/C). | Nat Struct Mol Biol | 2023 | 37735619 | PubTator, text mining | PubMed |
| Long non-coding RNA AC099850.4 correlates with advanced disease state and predicts worse prognosis in triple-negative breast cancer. | Front Med (Lausanne) | 2023 | 37727755 | PubTator, text mining | PubMed |
| Bioinformatical analysis of the key differentially expressed genes for screening potential biomarkers in Wilms tumor. | Sci Rep | 2023 | 37717078 | PubTator, text mining | PubMed |
| Identification of pivotal genes with prognostic evaluation value in lung adenocarcinoma by bioinformatics analysis. | Cell Mol Biol (Noisy-le-grand) | 2023 | 37715381 | PubTator, text mining | PubMed |
| Histological diagnosis of polyploidy discriminates an aggressive subset of hepatocellular carcinomas with poor prognosis. | Br J Cancer | 2023 | 37715023 | PubTator, text mining | PubMed |
| An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers. | Cancer Res Commun | 2023 | 37707389 | PubTator, text mining | PubMed |
| Determinants of response to CDK4/6 inhibitors in the real-world setting. | NPJ Precis Oncol | 2023 | 37704753 | PubTator, text mining | PubMed |
| Divergent CD4+ T-cell profiles are associated with anti-HLA alloimmunization status in platelet-transfused AML patients. | Front Immunol | 2023 | 37701444 | PubTator, text mining | PubMed |
| Ribonucleotide reductase regulatory subunit M2 (RRM2) as a potential sero-diagnostic biomarker in non-small cell lung cancer. | PLoS One | 2023 | 37699023 | PubTator, text mining | PubMed |
| TNFR1 and TNFR2, Which Link NF-κB Activation, Drive Lung Cancer Progression, Cell Dedifferentiation, and Metastasis. | Cancers (Basel) | 2023 | 37686574 | PubTator, text mining | PubMed |
| ELOVL6 is associated with immunosuppression in lung adenocarcinoma through bioinformatics analysis. | Medicine (Baltimore) | 2023 | 37682172 | PubTator, text mining | PubMed |
| Prognostic value of cell division cycle-associated protein-3 in prostate cancer. | Medicine (Baltimore) | 2023 | 37682152 | PubTator, text mining | PubMed |
| Non-IgE-reactive allergen peptides deteriorate the skin barrier in house dust mite-sensitized atopic dermatitis patients. | Front Cell Dev Biol | 2023 | 37675143 | PubTator, text mining | PubMed |
| How single-cell techniques help us look into lung cancer heterogeneity and immunotherapy. | Front Immunol | 2023 | 37671151 | PubTator, text mining | PubMed |
| Integrated analysis of the ubiquitination mechanism reveals the specific signatures of tissue and cancer. | BMC Genomics | 2023 | 37667177 | PubTator, text mining | PubMed |
| Comprehensive Analysis to Identify Rh Family C Glycoprotein (RHCG) as the Causative Gene for Psoriasis and Search for Alternative Treatment Modalities. | Drug Des Devel Ther | 2023 | 37664450 | PubTator, text mining | PubMed |
| Machine learning-based identification of glycosyltransferase-related mRNAs for improving outcomes and the anti-tumor therapeutic response of gliomas. | Front Pharmacol | 2023 | 37663248 | PubTator, text mining | PubMed |
| Delineating intra-tumoral heterogeneity and tumor evolution in breast cancer using precision-based approaches. | Front Genet | 2023 | 37662839 | PubTator, text mining | PubMed |
| Genetics in ophthalmology: molecular blueprints of retinoblastoma. | Hum Genomics | 2023 | 37658463 | PubTator, text mining | PubMed |
| Photo-click hydrogels for 3D in situ differentiation of pancreatic progenitors from induced pluripotent stem cells. | Stem Cell Res Ther | 2023 | 37649117 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11065/papers?page=15